Bronte Capital Management Pty Ltd.
CIK: 0001471085Latest portfolio: $1.0B · Q4 2025
Holdings
43
Total Value
$1.0B
New Positions
40
Closed Positions
0
Top Holdings
View All 43 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | REGNREGENERON PHARMACEUTICALS | 236,068 | $182.2M | 18.17% | NEW | Call |
| 2 | GOOGLALPHABET INC | 415,963 | $130.2M | 12.99% | NEW | |
| 3 | IBKRINTERACTIVE BROKERS GROUP | 1,486,294 | $95.6M | 9.53% | NEW | |
| 4 | —VISA INC-CLASS A SHARES | 235,154 | $82.5M | 8.23% | NEW | |
| 5 | BRK/BBERKSHIRE HATHAWAY INC DEL | 162,327 | $81.6M | 8.14% | NEW | |
| 6 | AMZNAMAZON COM INC | 277,641 | $64.1M | 6.39% | NEW | |
| 7 | 4I1PHILIP MORRIS INTL INC | 398,556 | $63.9M | 6.38% | NEW | |
| 8 | COFCAPITAL ONE FINL CORP | 175,540 | $42.5M | 4.24% | NEW | |
| 9 | CTVACORTEVA INC | 569,033 | $38.1M | 3.80% | NEW | |
| 10 | FCNCAFIRST CTZNS BANCSHARES INC N | 17,072 | $36.6M | 3.65% | NEW | |
| 11 | —VANECK ETF TRUST | 217,657 | $18.7M | 1.86% | NEW | |
| 12 | ALNYALNYLAM PHARMACEUTICALS INC | 38,864 | $15.5M | 1.54% | NEW | |
| 13 | SHCSOTERA HEALTH CO | 874,926 | $15.4M | 1.54% | NEW | |
| 14 | GHCGRAHAM HLDGS CO | 13,355 | $14.7M | 1.46% | NEW | |
| 15 | HLFHERBALIFE NUTRITION LTD | 1,120,175 | $14.4M | 1.44% | NEW | |
| 16 | PINSPINTEREST INC | 512,196 | $13.3M | 1.32% | NEW | |
| 17 | TBBBBBB FOODS INC | 394,158 | $13.2M | 1.31% | NEW | |
| 18 | IBBISHARES TR | 72,350 | $12.2M | 1.22% | NEW | |
| 19 | SQMSOCIEDAD QUIMICA Y MINERA DE | 163,457 | $11.2M | 1.12% | NEW | |
| 20 | S7VSALLY BEAUTY HLDGS INC | 737,250 | $10.5M | 1.05% | NEW | |
| 21 | NEMNEWMONT CORP | 77,856 | $7.8M | 0.78% | NEW | |
| 22 | BBARRICK MNG CORP | 164,856 | $7.2M | 0.72% | NEW | |
| 23 | RAMPLIVERAMP HLDGS INC | 231,994 | $6.8M | 0.68% | NEW | |
| 24 | BBWIBATH & BODY WORKS INC | 254,611 | $5.1M | 0.51% | NEW | |
| 25 | MDLZMONDELEZ INTL INC | 64,547 | $3.5M | 0.35% | NEW |
Quarterly Changes
Sector Breakdown
Healthcare0.0% ($1.8221215454154332e+26T)
Unknown0.0% ($8.247081593639281e+23T)
Financial Services0.0% ($95583425433663.9T)
Consumer Defensive0.0% ($14671144391316.0T)
Basic Materials0.0% ($381421124.6T)
Technology0.0% ($6813264.9T)
Communication Services0.0% ($13.0T)
Consumer Cyclical0.0% ($640.9B)
Industrials0.0% ($84K)
Filing History
| Quarter | Filing Date | Portfolio Value | Holdings |
|---|---|---|---|
| Q4 2025 | Feb 3, 2026 | $1.0B | 44 |
| Q3 2025 | Nov 5, 2025 | $1.1T | 0 |
| Q2 2025 | Aug 12, 2025 | $1.3T | 27 |
| Q1 2025 | May 14, 2025 | $1.2T | 26 |
| Q4 2024 | Feb 10, 2025 | $1.3T | 24 |
| Q3 2024 | Nov 5, 2024 | $1230.5T | 25 |
| Q2 2024 | Aug 7, 2024 | $1277.5T | 28 |
| Q1 2024 | May 13, 2024 | $1225.2T | 30 |
| Q4 2023 | Feb 7, 2024 | $1119.4T | 30 |
| Q3 2023 | Nov 6, 2023 | $992.8T | 28 |
| Q2 2023 | Aug 8, 2023 | $1036.6T | 32 |
| Q1 2023 | May 12, 2023 | $861.9T | 30 |
| Q4 2022 | Feb 14, 2023 | $792.6B | 27 |
| Q3 2022 | Nov 3, 2022 | $802.9B | 28 |
| Q2 2022 | Aug 8, 2022 | $872.5B | 32 |
| Q1 2022 | May 13, 2022 | $1.2T | 31 |
| Q4 2021 | Feb 10, 2022 | $1.5T | 29 |
| Q3 2021 | Nov 9, 2021 | $1.4T | 27 |
| Q2 2021 | Aug 9, 2021 | $1.4T | 21 |
| Q1 2021 | Apr 13, 2021 | $881.6B | 17 |
| Q4 2020 | Feb 3, 2021 | $632.9B | 15 |
| Q3 2020 | Nov 12, 2020 | $567.9B | 13 |
| Q2 2020 | Aug 10, 2020 | $582.2B | 12 |
| Q1 2020 | May 8, 2020 | $610.8B | 13 |
| Q4 2019 | Jan 29, 2020 | $515.5B | 9 |
| Q3 2019 | Nov 8, 2019 | $361.6B | 12 |
| Q2 2019 | Aug 13, 2019 | $280.6B | 11 |
| Q1 2019 | May 10, 2019 | $266.5B | 11 |
| Q4 2018 | Feb 13, 2019 | $250.7B | 10 |
Fund Information
Bronte Capital Management Pty Ltd. is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $1.0B across 43 holdings. The largest position is REGENERON PHARMACEUTICALS (REGN), representing 18.2% of the portfolio. Compared to the previous quarter, the fund opened 43 new positions and closed 0 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.